Skin Microbes Offer New Targets for Future Treatments
A review explores how sequencing skin microbes is revealing treatment targets—and why that does not yet validate commercial microbiome products.
Gut microbiome, probiotics, gut-brain axis, and digestive health
501 articles
A review explores how sequencing skin microbes is revealing treatment targets—and why that does not yet validate commercial microbiome products.
A fiber blend lowered blood androgens in a clinical trial, while experiments revealed a bacterial pathway that converts an androgen precursor.
A review of how gut microbes activate, inactivate, or hoard drugs, and why microbiome profiles may predict response to statins, immunotherapy, and antidepressants.
A new review maps the two-way link between GLP-1 drugs and gut microbes, from short-chain fatty acids to bile acids, and what it could mean for personalized therapy.
A review of how skin and gut microbes drive atopic dermatitis, which early biomarkers predict it, and how probiotics and live bacterial transplants may help.
A clinical and laboratory study explores how oral bacteria activate gum immune defenses—and whether blocking STAT3 changes that response.
A clinical trial links inulin fiber to less knee arthritis pain and stronger grip, suggesting a possible gut–joint connection.
A bacterial lipid improved muscle energy metabolism and preserved muscle fiber size in male mice. Human benefits remain untested.
A soybean carbohydrate improved blood vessel function in aged mice, with gut-derived butyrate emerging as a potential link.
A University of Hawaii study links gut microbes to the pace of biological aging, with some species tied to slower aging and others to faster aging.
A narrative review of long COVID care finds no approved therapies, but pacing, ivabradine, low-dose naltrexone and probiotics show early promise for fatigue and POTS.
Gut bacteria convert plant sterols into sulfated forms found in mouse tissues. Sitosterol sulfate accumulates with age, but its effects on health remain unknown.